Evidence map›Paper›PMID 26446624›Full record

ArticleOrphanet journal of rare diseases2015

Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states.

Philippe Joly, Olivier Guillaud, Valérie Hervieu, Alain Francina, Jean-François Mornex, Colette Chapuis-Cellier

Abstract readCase Reports
In one paragraph

Article in Orphanet journal of rare diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Alpha-1 antitrypsin deficiency associated with rareRespiratory medicine case reports · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Clinical manifestations in patients with PI*MMRespirology case reports · 2020
    Article
  7. A rare mutation on alpha-1 antitrypsin deficit and lung fibrosis: case report.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2020
    Article
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Philippe JolyUnité de Pathologie Moléculaire du Globule Rouge, Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France. philippe.joly@chu-lyon.fr.
Olivier GuillaudService d'hépato-gastroentérologie, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France. olivier.guillaud@chu-lyon.fr.
Valérie HervieuService d'anatomie pathologique, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France. valerie.hervieu@chu-lyon.fr.
Alain FrancinaUnité de Pathologie Moléculaire du Globule Rouge, Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France. alain.francina@wanadoo.fr.
Jean-François MornexService de pneumologie, Groupement Hospitalier Est, Hospices Civils & Université Claude Bernard-Lyon 1, Bron, France. jean-francois.mornex@chu-lyon.fr.
Colette Chapuis-CellierLaboratoire d'Immunologie, Centre de Biologie Sud, Centre hospitalier Lyon-Sud, Hospices Civils & Université Claude Bernard-Lyon 1, Lyon, France. colette.cellier@chu-lyon.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlpha 1 antitrypsin (A1AT) deficiency (A1ATD) is potentially associated with a high degree of liver and/or lung disease. Apart from the most frequent deficiency alleles, Pi S and Pi Z, some A1AT alleles of clinical significance may be easily misdiagnosed. This is typically the case of the Pi Mmalton variant which shares the same 'gain-of-function' liver toxicity than Pi Z and the same 'loss of function' lung disease as well.

methodsThe biological diagnosis of A1ATD typically relies on a low serum concentration associated with an abnormal isoelectric focusing (IEF) pattern of migration. However, Sanger direct DNA sequencing may be required for deficiency alleles without biochemical expression (Null alleles) or for A1AT variants whose IEF profiles resemble the wild-type and sub-types M allele but with a low concentration.

resultsWe report four cases of A1ATD involving the deficient Pi Mmalton allele with very different clinical expressions: (i) one Mmalton/Mmalton with liver fibrosis and cirrhosis, (ii) two Mmalton/Z with chronic pulmonary obstructive disease in one case and (iii) one M/Mmalton without liver or lung disease. In both cases, the correct diagnosis has necessitated a genetic analysis.

conclusionsOur study provides another example of Pi Mmalton homozygosity associated with a severe liver disease that emphasizes the necessity of a not delayed diagnosis. The great clinical heterogeneity of the other genotypes (which is in agreement with the literature data) questions about the role of environmental and other modifier genes in the pathogenicity of A1ATD.

Indexed as

AllelesHeterozygoteHomozygoteAdultAged, 80 and overalpha 1-Antitrypsinalpha 1-Antitrypsin DeficiencyBase SequenceFemaleHumansMaleMiddle AgedMolecular Sequence Dataalpha 1-Antitrypsin

Identifiers

PMID26446624
PMCPMC4596512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.